Sance Parenterals Private Limited

Sance Parenterals Private Limited - pharma in Kottayam, Kerala, India. FY 2026 financials & compliance.
CIN U24231KL2001PTC014916 Incorporated 03 September 2001 ROC Ernakulam HQ Kottayam, Kerala, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹2.11 Lakh
▲ 103% YoY
Net loss · FY 2024
₹6.74 Lakh
Net margin -319.1%
EBITDA · FY 2024
-₹6.74 Lakh
EBITDA margin -319.1%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Open charges
₹19.93 Cr
Secured borrowings
Company age
25 yrs
Est. 2001
Directors on board
4
As per MCA filings

About Sance Parenterals Private Limited

Data last updated:

Sance Parenterals Private Limited is a private limited company based in Kottayam, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 September 2001 and has been in existence for over 25 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL2001PTC014916.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors including Jatin Joseph and Manoj Joseph.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/173 Manjushas Pala P.O., Kottayam, Kerala, India – 686575.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.11 Lakh, a growth of 103% compared to the previous year. For the same year it recorded a net loss of ₹6.74 Lakh (net margin -319.1%) and EBITDA of -₹6.74 Lakh (EBITDA margin -319.1%). Revenue has declined at a compounded annual rate (CAGR) of 26% over five years.

As per MCA filings, the company has open charges of ₹19.93 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sancepharma.com.

Company details

CIN U24231KL2001PTC014916
Registration Number 014916
Incorporation Date 03 September 2001
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Sance Parenterals Private Limited's registered office is in Kottayam, Kerala. Its website is sancepharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    15/173 Manjushas Pala P.O., Kottayam, Kerala, India – 686575
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sance Parenterals Private Limited, buy the company report.

Comprehensive company report
Sance Parenterals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Sance Parenterals Private Limited

FY 2025 filings available

Sance Parenterals Private Limited reported revenue of ₹2.11 Lakh (up 103% YoY) for FY 2024.

Revenue · FY 2024
₹2.11 Lakh ▲ 103%
Net loss · FY 2024
₹6.74 Lakh margin -319.1%
EBITDA · FY 2024
-₹6.74 Lakh margin -319.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 103%
5 years · compounded
▼ 26%
EBITDA CAGR growth
1 year
▼ 210%
5 years · compounded
▼ 25%

Revenue rose 103% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 26%. EBITDA fell 210% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹6.74 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹6.74 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-319.1%
Net Profit Margin-319.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sance Parenterals Private Limited, buy the company report.

Board of directors of Sance Parenterals Private Limited

Sance Parenterals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Joseph ManojAdditional Director07 Jul 20251 Years 3 MonthsCurrent
Jatin JosephDirector03 Sep 200125 Years 1 MonthsCurrent
Manoj JosephDirector03 Sep 200125 Years 1 MonthsCurrent
Joby PaulAdditional Director07 Jul 20251 Years 3 MonthsCurrent

Auditor

Sance Parenterals Private Limited is audited by N UNNIKRISHNAN & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
N UNNIKRISHNAN & ASSOCIATESFY 2022004461S

Shareholding

The shareholding of Sance Parenterals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sance Parenterals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹19.93 Cr
Satisfied charges
None
Breakdown by lending institutions
Canara Bank₹19.93 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Nov 200810133762Canara Bank₹19.93 CrOpen

To see the full charge records of Sance Parenterals Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sance Parenterals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Sance Parenterals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Sance Parenterals Private Limited has 7 board changes on record since 2001: 4 appointments and 3 cessations. The latest: Joby Paul was appointed as Additional Director on 07 Jul 2025.

AGM
Sance Parenterals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Joby Paul was appointed as Additional Director.
Appointed
Joseph Manoj was appointed as Additional Director.
Ceased
Thommas Paul ceased to be Director.
Ceased
Valsamma Joseph ceased to be Managing Director.
Charges
A charge with Canara Bank of Rs. 1,992.50 Lakh registered on 18 Nov 2008 with Charge ID 10133762 was modified on 04 Apr 2025.
Filing
Sance Parenterals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Ceased
Paul Thomas ceased to be Director.
Charges
A charge with Canara Bank amounted to Rs. 1,992.50 Lakh with Charge ID 10133762 was registered on 18 Nov 2008.
Appointed
Jatin Joseph was appointed as Director.
Appointed
Manoj Joseph was appointed as Director.
Incorporation
03 Sep 2001
Sance Parenterals Private Limited was registered on 03 Sep 2001 with Roc Ernakulam & aged 25 years 1 month as per MCA records.

Frequently asked questions

Sance Parenterals is an active private limited company based in Kottayam, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 September 2001 (25+ years old) and is registered under CIN U24231KL2001PTC014916.

Sance Parenterals has 4 current directors:

The latest financial statements of Sance Parenterals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Sance Parenterals is U24231KL2001PTC014916. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sance Parenterals was incorporated on 03 September 2001, making it 25+ years old. It is registered with the Registrar of Companies, Ernakulam.

Joby Paul was appointed as Additional Director on 07 Jul 2025. Joseph Manoj was appointed as Additional Director on 07 Jul 2025. Thommas Paul ceased to be Director on 30 Jun 2025. Sance Parenterals has 7 board changes on record in total.

Sance Parenterals can be reached through the website sancepharma.com. Its registered office is in Kottayam, Kerala, India.

The registered office of Sance Parenterals is at 15173 Manjushas Pala P.O., Kottayam, Kerala, India – 686575.

Sance Parenterals operates in the pharma industry, in the drug formulation and development segment.

Sance Parenterals has open charges of ₹19.93 Cr and no satisfied charges on record as per latest MCA filings.